
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In add... Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 13.68 | 3.07408822274 | 445.01 | 460.33 | 437.45 | 1115249 | 448.69986012 | CS |
4 | 34 | 8.00583955356 | 424.69 | 460.33 | 421.76 | 1400315 | 442.90894722 | CS |
12 | -51.3 | -10.0590207651 | 509.99 | 515.67 | 416.6 | 1743540 | 464.38421448 | CS |
26 | -7.83 | -1.67838463517 | 466.52 | 519.68 | 377.85 | 1687198 | 455.59400582 | CS |
52 | -19.31 | -4.03974895397 | 478 | 519.88 | 377.85 | 1410055 | 464.00641516 | CS |
156 | 208.82 | 83.5714571577 | 249.87 | 519.88 | 243.17 | 1329393 | 386.02103312 | CS |
260 | 190.57 | 71.0763837088 | 268.12 | 519.88 | 176.36 | 1530350 | 308.5949634 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions